Frauenheilkunde up2date, Table of Contents Frauenheilkunde up2date 2016; 10(05): 439-453DOI: 10.1055/s-0042-113795 Gynäkologische Spezialgebiete und Methoden Georg Thieme Verlag KG Stuttgart · New YorkFetomaternale Blutgruppenunverträglichkeiten – Update 2016 Anke RedlichRecommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Geifman-Holtzman O, Wojtowycz M, Kosmas E et al. Female alloimmunization with antibodies known to cause haemolytic disease. Obstet Gynecol 1997; 89: 272-275 2 Vaughan J, Manning M, Warwick R et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338: 798-803 3 Heathcote DJ, Carroll TE, Flower RL. Sixty years of antibodies to MNS system hybrid glycophorins: what have we learned?. Transfus Med Rev 2011; 25: 111-124 4 Hendrickson JE, Delaney M. Hemolytic disease of the fetus and newborn: modern practice and future investigations. Transfus Med Rev 2016; 5 Behrens O, Bader W, Holle W et al. Antikörper-Nachweis nach antepartaler Rhesus-Prophylaxe: Normalfall oder Sensibilisierung?. Geburtsh Frauenheilk 1993; 53: 342-345 6 Bekanntmachung der Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten gemäß §§ 12 und 18 des Transfusionsgesetzes vom 19.09.2005. 7 Virk M, Sandler G. Rh immunoprophylaxis for women with a serologic weak D phenotype. Lab Med 2015; 46: 190-194 8 Cherif-Zahar B, Mattei MG, Le Van Kim C et al. Localization of the human Rh blood group gene structure to chromosome region 1p34.3-1p36.1 by in situ hybridization. Hum Genet 1991; 86: 398-400 9 Flegel WA. Genetik des Rhesus-Blutgruppensystems. Dtsch Arztebl 2007; 104: A651-A657 10 Wagner FF, Frohmajer A, Ladewig B et al. Weak alleles express distinct phenotypes. Blood 2000; 95: 2699-2708 11 Bennett PR, Le Van Kim C, Colin Y et al. Prenatal Determination of fetal RhD type by DNA Amplification. N Engl J Med 1993; 329: 607-610 12 Singleton BK, Green CA, Avent ND et al. The presence of a RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000; 95: 12-18 13 Lo YM, Tein MS, Lau TK et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-775 14 Daniels G, Finning K, Martin P et al. Fetal blood group genotyping: present and future. Ann N Y Acad Sci 2006; 1075: 88-95 15 Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of non-invasive fetal Rh genotyping from maternal blood – a meta-analysis. Am J Obstet Gynecol 2006; 195: 1163-1173 16 Finning K, Martin P, Daniels G. The Use of maternal Plasma for prenatal Blood Group Genotyping. In: Bugert P, ed. DNA and RNA Profiling in human Blood: Methods and Protocols. New York: Humana Press; 2009: 143-157 17 Oepkes D, van Kamp IL, Simon MJ et al. Clinical value of an antibody-dependent cell-mediated cytotoxocity assay in the management of Rh D alloimmunization. Am J Obstet Gynecol 2001; 184: 1015-1020 18 Oepkes D. Das niederländische nationale Screening-Programm zur Alloimmunisierung. Frauenarzt 2016; 57: 686-689 19 Mari G, Adrignolo A, Abuhamad AZ et al. Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization. Ultrasound Obstet Gynecol 1995; 5: 400-405 20 Mari G. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med 2000; 342: 9-14 21 Pretlove SJ, Fox CE, Khan KS et al. Noninvasive methods of detecting fetal anaemia. A systematic review and meta-analysis. Br J Obstet Gynaecol 2009; 116: 1558-1567 22 McKenna DS, Nagaraja HN, OʼShaugnessy R. Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol 1999; 93: 667-673 23 Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J 1963; 2: 1107-1109 24 Leduc L, Moise jr. KJ. Prediction of fetoplacental blood volume in isoimmunized pregnancy. Am J Obstet Gynecol 1990; 162: 1124 25 Detti L, Oz U, Guney I et al. Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization. Am J Obstet Gynecol 2001; 185: 1048-1051 26 van Kamp IL, Klumper FJ, Oepkes D et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005; 192: 171-177 27 Lindenburg IT, Smits-Wintjens VE, van Klink JM. on behalf of the LOTUS study group. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol 2012; 206: 141.e1-8 28 Oepkes D. Das niederländische nationale Screening-Programm zur Alloimmunisierung. Frauenarzt 2016; 57: 686-689 29 Whitecar PW, Farb R, Subramanyam L et al. Paternal leukocyte alloimmunization as a treatment for hemolytic disease of the newborn in a rabbit model. Am J Obstet Gynecol 2002; 187: 977-980 30 Hall AM, Cairns LS, Altmann DM et al. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 2005; 105: 2175-2179
